MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0015791
Actimus Biosciences Private Limited - life sciences in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.57 Cr
▲ 10% YoY
Net profit · FY 2025
₹6.06 Cr
Net margin 11.3%
EBITDA · FY 2025
₹10.58 Cr
EBITDA margin 19.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹28.38 Cr
Satisfied ₹5.35 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
273
Provident fund records
About Actimus Biosciences Private Limited
Data last updated:
Actimus Biosciences Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Actimus Inc. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 January 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74140AP2004PTC042512. Its GSTIN is 37AACCT1298A2ZH (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It was formerly known as Tavisa Biosciences Private Limited. It is led by directors including Ajjagottu Ramanathareddy (Managing Director) and Devadi Srinivasa Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Varun Towers 7 – 8 – 1/3 Kasturigba Marg Siripuram, Visakhapatnam, Andhra Pradesh, India – 530003.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.57 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹6.06 Cr (net margin 11.3%) and EBITDA of ₹10.58 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 18% over five years.
The company has about 273 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Actimus Bio. As per MCA filings, the company has open charges of ₹28.38 Cr and satisfied charges of ₹5.35 Cr on record. Court records list 5 cases involving the company, including 5 filed against it. The company has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023. Its 10 peer companies in the Biotechnology industry (Biosciences, Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Ross Lifescience Limited with revenue of ₹56.54 Cr.
Actimus Biosciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0015791). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actimusbio.com.
Company Details of Actimus Biosciences Private Limited
CIN U74140AP2004PTC042512
Registration Number 042512
Incorporation Date 28 January 2004
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Actimus Inc
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0015791
Key People
Ajjagottu Ramanathareddy Managing Director Devadi Srinivasa Rao Director Devadi Shiva Kumar Director Recognitions & Rankings of Actimus Biosciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address4th Floor Varun Towers 7 – 8 – 1/3 Kasturigba Marg Siripuram, Visakhapatnam, Andhra Pradesh, India – 530003
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Actimus Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Actimus Biosciences Private Limited
Actimus Biosciences operates one associated brand: Actimus Bio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers bioanalytical, clinical trials, and analytical services for drug development globally. | actimusbio.com |
Business Activity of Actimus Biosciences Private Limited
The main business activity of Actimus Biosciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Actimus Biosciences Private Limited FY 2025 filings available
Actimus Biosciences Private Limited reported revenue of ₹53.57 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹53.57 Cr ▲ 10%
Net profit · FY 2025
₹6.06 Cr margin 11.3%
EBITDA · FY 2025
₹10.58 Cr margin 19.8%
Compounded Annual Growth Rate (CAGR) of Actimus Biosciences Private Limited
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 21%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 45%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 10% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Actimus Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.58 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.06 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Actimus Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Actimus Biosciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Actimus Biosciences Private Limited
Actimus Biosciences has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devadi Srinivasa Rao | Director | 26 Mar 2013 | 13 Years 6 Months | Current |
| Ajjagottu Ramanathareddy | Managing Director | 28 Jan 2004 | 22 Years 8 Months | Current |
| Devadi Shiva Kumar | Director | 26 Jul 2025 | 1 Years 2 Months | Current |
Peer Comparison of Actimus Biosciences Private Limited
Actimus Biosciences Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biosciences, Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ross Lifescience Limited | ₹56.54 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Pune, Maharashtra, India |
| Biofusion Therapeutics Limited | ₹56.53 Cr (FY 2023) | •••• | •••• | 41.0% | •••• | Bengaluru, Karnataka, India |
| Yapan Bio Private Limited | ₹55.8 Cr (FY 2025) | •••• | •••• | 87.0% | •••• | Shameerpet, Telangana, India |
| 3B Blackbio Biotech India Limited | ₹55.39 Cr (FY 2023) | •••• | •••• | -25.0% | •••• | Bhopal, Madhya Pradesh, India |
| Emesar Vaigyanik Annusandhan Kendra (A Private Company) | ₹54.38 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Actimus Biosciences Private Limited this company | ₹53.57 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Khandwa Bio-Tech Private Limited | ₹52.86 Cr (FY 2025) | •••• | •••• | 577.0% | •••• | Indore, Madhya Pradesh, India |
| Chemtek Scientific Private Limited | ₹52.2 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Thane, Maharashtra, India |
| SSK Biosciences Private Limited | ₹49.41 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Navkisan Bio Plaantec Limited | ₹47.15 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | Hyderabad, Telangana, India |
| Aumgene Biosciences Private Limited | ₹46.06 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Surat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Actimus Biosciences by revenue in the Biotechnology industry (Biosciences, Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Actimus Biosciences Private Limited
Actimus Biosciences Private Limited is audited by M K M and CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M K M and CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Actimus Biosciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Actimus Biosciences Private Limited
Open charges
₹28.38 Cr
Satisfied charges
₹5.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2025 | Hdfc Bank Limited | ₹28.38 Cr | Open |
| 01 Oct 2015 | Canara Bank | ₹3.5 Cr | Satisfied |
| 16 Apr 2011 | State Bank of India | ₹85 Lakh | Satisfied |
| 18 Nov 2008 | State Bank of India | ₹1 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Actimus Biosciences Private Limited
Actimus Biosciences Private Limited has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023.
Total deals
10
Secondary share transfers
5
Funding rounds
4
Rights issue
1
Disclosed funding
₹3.06 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Actimus Inc |
| Jul 2018 | Rights issue | ₹2.21 Cr | Investors: Actimus Inc |
| Mar 2017 | Funding round | ₹47.1 Lakh | Investors: Actimus Inc |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: Actimus Inc Seller: 2 individuals |
Premium access
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Actimus Biosciences Private Limited
Actimus Biosciences Private Limited has 5 court cases on record: 5 filed against it. All cases are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Total cases
5
Filed against the company
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Transasia Bio-Medicals Limited | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Actimus Biosciences Private Limited
Actimus Biosciences Private Limited has a workforce of 273 employees as of Apr 02, 2024.
Employee count
273
Active EPFO establishments
1
Employee growth
20.8%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Actimus Biosciences Private Limited
Actimus Biosciences Private Limited has 11 board changes on record since 2004: 4 appointments and 7 cessations. The latest: Devadi Shiva Kumar was appointed as Director on 26 Jul 2025.
AGM
Actimus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Devadi Shiva Kumar was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 28.38 Cr with Charge ID 101106404 was registered on 30 May 2025.
Filing
Actimus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge registered on 01 Oct 2015 via Charge ID 100029051 with Canara Bank was fully satisfied on 03 Jul 2023.
Appointed
Devadi Pavan Kumar was appointed as Additional Director.
Ceased
Devadi Srinivasa Rao ceased to be Director.
Ceased
Manoj Lanka ceased to be Additional Director.
Charges
A charge registered on 16 Apr 2011 via Charge ID 10288052 with State Bank Of India was fully satisfied on 18 Jan 2017.
Charges
A charge registered on 18 Nov 2008 via Charge ID 10132732 with State Bank Of India was fully satisfied on 18 Jan 2017.
Charges
A charge with Canara Bank amounted to Rs. 3.50 Cr with Charge ID 100029051 was registered on 01 Oct 2015.
Ceased
Srinivas Reddy Maram ceased to be Director.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Actimus Biosciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Actimus Biosciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Actimus Biosciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Actimus Biosciences Private Limited
Actimus Biosciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCT1298A2ZH | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Actimus Biosciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actimus Biosciences Private Limited
Actimus Biosciences is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 January 2004 (22+ years old) and is registered under CIN U74140AP2004PTC042512.
Actimus Biosciences reported revenue of ₹53.57 Cr for FY 2025 (up 10% YoY).
Actimus Biosciences has 3 current directors:
- Ajjagottu Ramanathareddy - Managing Director
- Devadi Srinivasa Rao - Director
- Devadi Shiva Kumar - Director
Actimus Biosciences reported a net profit of ₹6.06 Cr (net margin 11.3%) and EBITDA of ₹10.58 Cr (EBITDA margin 19.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Actimus Biosciences is 21% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Actimus Biosciences is 37AACCT1298A2ZH, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Actimus Biosciences is U74140AP2004PTC042512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actimus Biosciences has 5 court cases on record: 5 filed against it.
Actimus Biosciences was incorporated on 28 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Vijayawada.
Actimus Biosciences has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023.
The peers of Actimus Biosciences by revenue are Ross Lifescience Limited, Biofusion Therapeutics Limited, Yapan Bio Private Limited, 3B Blackbio Biotech India Limited, Emesar Vaigyanik Annusandhan Kendra (A Private Company) and 5 more, all in the Biotechnology industry (Biosciences, Biotechnology).